SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,459,560 | +109.4% | 16,050 | -51.0% | 6.34% | +90.5% |
| Q1 2023 | $4,516,689 | -48.4% | 32,770 | -51.5% | 3.33% | -38.2% |
| Q4 2022 | $8,746,650 | +90.7% | 67,500 | +62.7% | 5.38% | +172.6% |
| Q3 2022 | $4,587,000 | -42.2% | 41,500 | -30.8% | 1.98% | +39.9% |
| Q2 2018 | $7,931,000 | +478.1% | 60,000 | +20.0% | 1.41% | +176.9% |
| Q4 2016 | $1,372,000 | -75.1% | 50,000 | -44.3% | 0.51% | -75.3% |
| Q3 2016 | $5,509,000 | +37.6% | 89,700 | -57.3% | 2.07% | +7.5% |
| Q2 2016 | $4,005,000 | +38.4% | 210,000 | +180.0% | 1.92% | +39.0% |
| Q4 2015 | $2,894,000 | +184.0% | 75,000 | +136.3% | 1.38% | +134.6% |
| Q3 2015 | $1,019,000 | – | 31,744 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |